About this Research Topic
Due to modern risk- and response-adapted therapeutic modalities, Hodgkin lymphoma (HL) treatment has become a twentieth century success story, with the number of long-term HL survivors increasing thanks to favorable treatment results. However, many HL patients are in early adulthood (median age of about 30 years), so the maintenance of a good quality of life (QoL) after treatment completion is crucial. Many promising studies have focused on survival-related issues in former HL patients, mainly addressing overall health-related (HR) QoL. HRQoL, as a multidimensional construct, is based on the World Health Organization's definition of health, incorporating physical, mental, and social aspects. HRQoL may be impaired due to treatment-induced organic dysfunctions, psychological consequences, fatigue, persisting gonadal and cognitive dysfunction, and difficulties in social and role functioning in HL survivors.
Most of the existing published data on HRQoL in Hogkin lymphoma survivors comes from retrospective or cross-sectional studies. Only a few longitudinal clinical trials have addressed HRQoL among HL survivors. This Research Topic aims to provide insights into issues and complications affecting the HRQoL among long-term Hodgkin lymphoma survivors.
Important Note: Manuscripts consisting solely of bioinformatics, computational analysis, or predictions of public databases which are not accompanied by validation (independent cohort or biological validation in vitro or in vivo) will not be accepted in any of the sections of Frontiers in Oncology.
Most of the existing published data on HRQoL in Hogkin lymphoma survivors comes from retrospective or cross-sectional studies. Only a few longitudinal clinical trials have addressed HRQoL among HL survivors. This Research Topic aims to provide insights into issues and complications affecting the HRQoL among long-term Hodgkin lymphoma survivors.
Important Note: Manuscripts consisting solely of bioinformatics, computational analysis, or predictions of public databases which are not accompanied by validation (independent cohort or biological validation in vitro or in vivo) will not be accepted in any of the sections of Frontiers in Oncology.
Keywords: Hodgkin lymphoma, health-related quality of life, HRQoL, survivorship, hematologic malignancies, patient outcomes
Important Note: All contributions to this Research Topic must be within the scope of the section and journal to which they are submitted, as defined in their mission statements. Frontiers reserves the right to guide an out-of-scope manuscript to a more suitable section or journal at any stage of peer review.
